High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy

High-frequency 10-kHz SCS significantly decreased pain severity and provided additional clinically meaningful improvements in DQOL and overall functioning for patients with PDN. The robust and sustained benefits over 24 months, coupled with high participant satisfaction, highlight that 10-kHz SCS is an efficacious and comprehensive therapy for patients with PDN.

Authors

Institutions

Publication Details

Journal
Journal of Diabetes Science and Technology
Published
2024-10-06
DOI
https://doi.org/10.1177/19322968241268547
Citations
7
Primary Topic
Pain Management and Treatment
Type
article
Field-Weighted Citation Impact
4.49

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy

Maged Guirguis, Nathan John Harrison, Richard Bundschu, Dawood Sayed et al.
7 citations
Journal of Diabetes Science and Technology
Pain Management and Treatment
4.49
article

High-Frequency 10-kHz Spinal Cord Stimulation Provides Long-term (24-Month) Improvements in Diabetes-Related Pain and Quality of Life for Patients with Painful Diabetic Neuropathy

Maged Guirguis, Nathan John Harrison, Richard Bundschu, Dawood Sayed, David DiBenedetto, Nagy Mekhail, James Scowcroft, Charles E. Argoff, Neel Mehta, Paul Chang, Shawn Sills, Michael Creamer, Johnathan Goree, Michael J. Jaasma, Kasra Amirdelfan, Atef F. Israel, Cong Yu, David Caraway, Deborah Edgar, Vincent Galan, Khalid A. Sethi, Christian Nasr, Thomas Stauss, Erika Petersen, Jijun Xu, Ali Nairizi, Matthew T. Bennett, Shivanand P. Lad, Denis Patterson, Judith L. White, Paul W. Wu, Rod Stephen Taylor
article en
7 citations

Abstract

High-frequency 10-kHz SCS significantly decreased pain severity and provided additional clinically meaningful improvements in DQOL and overall functioning for patients with PDN. The robust and sustained benefits over 24 months, coupled with high participant satisfaction, highlight that 10-kHz SCS is an efficacious and comprehensive therapy for patients with PDN.

Journal of Diabetes Science and TechnologyVol. 20(1)
Cleveland Clinic (US), Ochsner Health System (US), University of Arizona (US), Duke University (US), Cornell University (US), Holy Cross Hospital (US), Pain Management Institute (US), Swedish Medical Center (US), Kaiser Permanente Walnut Creek Medical Center (US), Medical Advanced Pain Specialists (US), MRC/CSO Social and Public Health Sciences Unit (GB), United Health Services (US), Coastal Orthopedics (US), Nevro (United States) (US), University of Kansas Medical Center (US), Center for Pain and the Brain (US), Central Florida Pulmonary Group (US), Albany Medical Center Hospital (US), University of Glasgow (GB), University of Arkansas for Medical Sciences (US)
Abbott Laboratories, Boston Scientific Corporation, Saluda Medical, SPR Therapeutics, Nevro
Openalex Percentile: Top 5%
Pain Management and Treatment
4.49
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.